Dashboard
Manage Tickers

BDTXBlack Diamond Therapeutics,...

Nasdaq blackdiamondtherapeutics.com


$ 6.97 $ 0.37 (5.61 %)    

Friday, 03-May-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 6.96
$ 6.80
$ 0.00 x 0
$ 0.00 x 0
$ 6.60 - $ 7.08
$ 1.53 - $ 7.14
842,381
na
305.92M
$ 1.71
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-12-2024 12-31-2023 10-K
2 11-06-2023 09-30-2023 10-Q
3 08-11-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-Q
5 03-09-2023 12-31-2022 10-K
6 11-08-2022 09-30-2022 10-Q
7 08-09-2022 06-30-2022 10-Q
8 05-11-2022 03-31-2022 10-Q
9 03-17-2022 12-31-2021 10-K
10 11-08-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-07-2021 03-31-2021 10-Q
13 03-25-2021 12-31-2020 10-K
14 11-10-2020 09-30-2020 10-Q
15 08-11-2020 06-30-2020 10-Q
16 05-12-2020 03-31-2020 10-Q
17 03-24-2020 12-31-2019 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/23/2024 20:31:12

wedbush-maintains-outperform-on-black-diamond-therapeutic-raises-price-target-to-16
Wedbush Maintains Outperform on Black Diam...
04/08/2024 15:18:17

Wedbush analyst Robert Driscoll maintains Black Diamond Therapeutic (NASDAQ:BDTX) with a Outperform and raises the price tar...

black-diamond-therapeutics-presented novel-real-world-evidence-of-the-evolving-egfr-mutation-landscape-in-nsclc-and-the-opportunity-for-bdtx-1535-in-an-oral-presentation-at-the-2024-aacr-annual-meeting
Black Diamond Therapeutics Presented Novel...
04/08/2024 06:15:24

Real-world data demonstrate non-classical mutations are present in 20-30% of all patients with EGFRm NSCLC Emerging data sho...

hc-wainwright--co-reiterates-buy-on-black-diamond-therapeutic-raises-price-target-to-12
HC Wainwright & Co. Reiterates Buy on Blac...
03/18/2024 10:46:13

HC Wainwright & Co. analyst Robert Burns reiterates Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and raises the pr...

wedbush-reiterates-outperform-on-black-diamond-therapeutic-maintains-10-price-target
Wedbush Reiterates Outperform on Black Dia...
03/13/2024 13:40:43

Wedbush analyst Robert Driscoll reiterates Black Diamond Therapeutic (NASDAQ:BDTX) with a Outperform and maintains $10 price...

black-diamond-therapeutic-q4-earnings-insights
Black Diamond Therapeutic: Q4 Earnings Ins...
03/12/2024 21:05:23

black-diamond-therapeutic-q4-eps-034-beats-047-estimate-cash-cash-equivalents-and-investments-of-1314m-expected-to-be-sufficient-to-fund-operations-into-q2-of-2025
Black Diamond Therapeutic Q4 EPS $(0.34) B...
03/12/2024 12:11:22

Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimat...

black-diamond-therapeutics-announces-expected-2024-milestones-co-exploring-the-potential-development-of-bdtx-1535-in-first-line-patients-who-are-post-osimertinib-adjuvant-treatment
Black Diamond Therapeutics Announces Expec...
01/04/2024 13:09:10

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
12/13/2023 17:31:35

black-diamond-therapeutics-announces-topline-results-from-phase-1-dose-escalation-trial-of-bdtx-1535-for-recurrent-glioblastoma-initial-results-show-promising-clinical-activity-in-heavily-pretreated-patients
Black Diamond Therapeutics Announces Topli...
12/13/2023 12:04:17

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
12/08/2023 13:07:06

hc-wainwright--co-reiterates-buy-on-black-diamond-therapeutic-maintains-11-price-target
HC Wainwright & Co. Reiterates Buy on Blac...
11/22/2023 11:25:11

HC Wainwright & Co. analyst Robert Burns reiterates Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and maintains $11...

black-diamond-therapeutic-q3-eps-045-beats-046-estimate-cash-cash-equivalents-and-investments-of-1443m-expected-to-be-sufficient-to-fund-operations-into-1h-of-2025
Black Diamond Therapeutic Q3 EPS $(0.45) B...
11/06/2023 12:17:28

Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimat...

black-diamond-therapeutics-and-2-other-stocks-under-3-insiders-are-buying
Black Diamond Therapeutics And 2 Other Sto...
10/20/2023 12:55:10

The Dow Jones closed lower by around 250 points on Thursday. When insiders purchase or sell shares, it indicates their confiden...

black-diamond-therapeutics-presented-dose-escalation-data-demonstrating-durable-responses-in-patients-with-nsclc-from-phase-1-trial-of-bdtx-1535-at-the-aacr-nci-eortc-international-conference
Black Diamond Therapeutics Presented Dose ...
10/16/2023 06:28:28

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
09/18/2023 17:35:21

black-diamond-therapeutics-appoints-mark-velleca-current-chairman-as-chief-executive-officer-effective-immediately-succeeding-the-companys-ceo-and-co-founder-david-epstein-who-has-stepped-down-and-will-continue-to-serve-as-a-board-member
Black Diamond Therapeutics Appoints Mark V...
09/18/2023 11:08:20

what-6-analyst-ratings-have-to-say-about-black-diamond-therapeutic
What 6 Analyst Ratings Have To Say About B...
09/12/2023 16:00:32

wedbush-reiterates-outperform-on-black-diamond-therapeutic-maintains-10-price-target
Wedbush Reiterates Outperform on Black Dia...
09/12/2023 14:12:32

Wedbush analyst Robert Driscoll reiterates Black Diamond Therapeutic (NASDAQ:BDTX) with a Outperform and maintains $10 price...

black-diamond-therapeutics-announces-first-patients-dosed-in-phase-1-clinical-trial-expansion-cohorts-evaluating-bdtx-1535-in-patients-with-intrinsic-driver-and-acquired-resistance-egfr-mutation-positive-non-small-cell-lung-cancer
Black Diamond Therapeutics Announces First...
09/11/2023 12:09:40

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX), a clinical-stage precision oncology company developing therapies that target fa...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION